Medicines Safety in the Globalized Context

Rabia Hussain, Mohamed Azmi Hassali, Zaheer-Ud-Din Babar

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter narrates pharmacoepidemiology, medicines safety, pharmacovigilance and adverse drug reaction mechanisms globally. It also discusses why a pharmacovigilance system is important in the current global scenario and how it improves patient health. The chapter describes a summary of best practices related to medicines safety. There are examples of pharmacovigilance from America, Canada, New Zealand and other developed and developing countries. It also synthesizes key literature and, at the end of this chapter, there is a case study on Pakistan’s pharmacovigilance set-up. The chapter also includes suggestions for the future research agenda to improve medicines safety globally.
Original languageEnglish
Title of host publicationGlobal Pharmaceutical Policy
EditorsZaheer-Ud-Din Babar
PublisherSpringer Singapore
Chapter1
Pages1-28
Number of pages28
Edition1st
ISBN (Electronic)9789811527241
ISBN (Print)9789811527234
DOIs
Publication statusPublished - 16 Jun 2020

Fingerprint Dive into the research topics of 'Medicines Safety in the Globalized Context'. Together they form a unique fingerprint.

  • Cite this

    Hussain, R., Azmi Hassali, M., & Babar, Z-U-D. (2020). Medicines Safety in the Globalized Context. In Z-U-D. Babar (Ed.), Global Pharmaceutical Policy (1st ed., pp. 1-28). Springer Singapore. https://doi.org/10.1007/978-981-15-2724-1_1